These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 829578)

  • 1. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition by somatostatin of the thyrotropin response to thyrotropin-releasing hormone in normal subjects.
    Weeke J; Hansen AP; Lundbaek K
    Scand J Clin Lab Invest; 1974 Apr; 33(2):101-3. PubMed ID: 4212424
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of atropine on growth hormone release in normal subjects and acromegaly.
    Zhang J; Lu JM; Huang ZJ
    Chin Med J (Engl); 1989 Jan; 102(1):45-7. PubMed ID: 2504552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly].
    Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M
    Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamics of growth hormone secretion in untreated acromegaly.
    Dash RJ; Rao NS; Sriprakash ML; Sialy R
    J Assoc Physicians India; 1987 May; 35(5):341-3. PubMed ID: 3121582
    [No Abstract]   [Full Text] [Related]  

  • 7. [The arginine test in functional semeiology of the incretion of the somatotrophic hormone].
    Giordano G; Marugo M; Minuto F; Barreca T
    Folia Endocrinol; 1971; 24(3):247-67. PubMed ID: 5171726
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
    Silvestrini F
    Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 10. The growth hormone responses to L-dopa and TRH in acromegaly.
    Jialal I; Naidoo C; Nathoo BC; Rajput MC; Joubert SM
    J Endocrinol Invest; 1984 Jun; 7(3):235-7. PubMed ID: 6432894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive glucagon responses to arginine in active acromegaly.
    Goldfine ID; Kirsteins L; Lawrence AM
    Horm Metab Res; 1972 Mar; 4(2):97-100. PubMed ID: 5063721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of thyrotropin releasing hormone (TRH) in normal subjects and in patients with thyroid gland diseases].
    Lauridsen UB; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Ugeskr Laeger; 1974 Jun; 136(25):1360-4. PubMed ID: 4210165
    [No Abstract]   [Full Text] [Related]  

  • 13. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism.
    Sachdev Y
    J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thyroid function in patients with anorexia nervosa and depression].
    Natori Y; Yamaguchi N; Koike S; Aoyama A; Tsuchibuchi S; Kojyo K; Demura R
    Rinsho Byori; 1994 Dec; 42(12):1268-72. PubMed ID: 7869591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE; Jacobs LS; Daughaday WH
    Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spontaneous diurnal variations as well as the effect of TRH, MIH and LH-RH on growth hormone secretion in active acromegaly].
    Heesen D; Hadam W; Mies R; Schorn H; Winkelmann W
    Verh Dtsch Ges Inn Med; 1975; 81():1521-3. PubMed ID: 5831
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Effect of growth hormone release inhibiting hormone on the release of growth hormone and other pituitary hormones in man.
    Schally AV; Coy DM; Kastin AJ; Tunbridge WM; Evered DC; Weightman D; Hall R; Besser GM; Goldie DJ; McNeilly AS; Mortimer CH; Phenekos C
    J Endocrinol; 1974 Apr; 61(1):XIV. PubMed ID: 4208301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly].
    Candrina R
    Medicina (Firenze); 1988; 8(2):180-1. PubMed ID: 3147351
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa.
    Lomeo A; Mazzocchi G; Sessarego P; Torre R; Delmonte P; Giusti M
    Recenti Prog Med; 1989 Nov; 80(11):569-73. PubMed ID: 2516349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.